(Q42504878)

English

A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

author name string

Roberto W Dal Negro

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Claudio Micheletto

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Silvia Tognella

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Marilia Visconti

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Massimo Guerriero

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Marco F Sandri

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 March 2005

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

COPD: Journal of Chronic Obstructive Pulmonary Disease

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

7-16

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Infectious etiology of acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD.

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

The burden of COPD in Italy: results from the Confronting COPD survey

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Chronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Introduction: the role of bacterial infection in chronic bronchitis

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Do bacteria cause exacerbations of COPD?

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Exacerbations: etiology and pathophysiologic mechanisms

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system.

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Bacterial-induced release of inflammatory mediators by bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

A Coefficient of Agreement for Nominal Scales

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050680

21 January 2018

Identifiers

10.1081/COPD-200050680

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42504878&oldid=1959983813"